BASILDON, England, March 24, 2016 /PRNewswire/ --
Health and Social Services (HSSD) in Jersey has signed a contract with JAC to roll out their Chemotherapy Management System (CMS) product in the Oncology Department at The General Hospital to improve the service provided to cancer patients.
The General Hospital is a 250 bed hospital based in St Helier and serves the whole island, with a population of 100,000. The hospital has been using JAC's Pharmacy Management (PSC) system for a number of years; and the decision to implement CMS was the next step in their commitment to implementing an end-to-end medicines management platform.
CMS is a web-based solution for prescribing, scheduling and managing therapies for chemotherapy patients. The system's specialist functionality focuses on reducing errors, streamlining patient management and optimising efficiency. By rolling out CMS, HSSD aims to demonstrate the potential for e-prescribing to improve patient care in Oncology before rolling out an Electronic Prescribing and Medicines Administration (EPMA) system across the rest of the organisation.
On the new contract, Chief Pharmacist at the General Hospital, Paul McCabe, said: "We look forward to working with JAC and harnessing their expertise to build a system that will benefit our patients by not only improving on the existing operational and governance arrangements that the pharmacy and oncology departments have in place, but also improving their overall experience at our hospital."
Oncology Sales Manager at JAC, Len Slawinski, said: "The contract with HSSD in Jersey is an important step forward for JAC as our cancer-services customer base continues to grow. We have already signed contracts with a number of NHS Trusts, including: The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust; Heart of England NHS Foundation Trust; The Princess Alexandra Hospital NHS Trust; and, very soon, the Bedford Hospital NHS Trust too. The Jersey contract further demonstrates customer confidence and acceptance of our CMS product."
According to Head of Health IT in Jersey, Jeff Tate, the roll out of the CMS system will be up and running towards the end of 2016. "We've worked closely with JAC for a number of years now and are looking forward to tackling this exciting new project with them. Together I'm sure we can deliver a system that the hospital can be proud of and it will make a real difference to the care that we provide to our patients. This will also deliver another key component of the hospital electronic patient record," said Tate.
JAC is the UK's leading medicine management systems specialist, with the largest installed base of EPMA systems in UK hospitals. With over 35 years' experience within medicines management, JAC provides pharmacy stock control, e-prescribing and medicines administration as a single integrated solution along with associated services and third-party interfaces. JAC's systems are used in more than half of all NHS trusts in England as well as sites in Jersey, Scotland, Wales, Northern Ireland, Ireland, Norway and South Africa.
In May 1996, JAC was acquired by Mediware Inc and continues to operate as a wholly owned subsidiary. The acquisition by Mediware Inc created the world's largest supplier of medicines management systems for hospital pharmacies.
For more information about JAC products and services, visit our website at http://www.jac.co.uk
SOURCE JAC Medicines Management